French Competition Authority Fines a Pharmaceutical Laboratory EUR 25 Million for Anti-Generic Practices

Published date05 January 2018
Law FirmMcDermott Will & Emery
AuthorLionel Lesur,Elena Chutrova
Subject MatterEU,Generic Drugs,Disparagement,France,Antitrust Division,Health Care Providers,Pharmaceutical Industry,French Competition Authority

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT